期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

西妥昔单抗联合放射和化学疗法治疗晚期鼻咽癌患者的观察与护理

原文传递
导出
摘要 1病例介绍 患者男,54岁。体检时腹部彩色超声发现肝脏弥漫性占位病变,行正电子发射计算机断层扫描-CT检查提示除肝脏外,左侧鼻咽后壁标准摄取值明显增高结节,行鼻咽镜活检,诊断为：鼻咽低分化鳞状细胞癌伴多发肝转移,Ⅳb期,
作者 陈萍 张庆 周俊 唐伟林 李莎莎 胡义德
机构地区 第三军医大学新桥医院肿瘤三病区
出处 《华西医学》 CAS 2011年第5期798-798,共1页 West China Medical Journal
关键词 鼻咽癌患者 西妥昔单抗 化学疗法 正电子发射计算机断层扫描 低分化鳞状细胞癌 弥漫性占位病变 护理 晚期
分类号 R739.63 [医药卫生—肿瘤]
  • 相关文献

参考文献6

  • 1Tham I, Lu J. Controversies and challenges in the current management of nasopharyngeal cancer[J]. Expert Rev Antieaneer Ther, 2010, 10(9): 1439-1450.
  • 2Le Tourneau C, Siu L. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck[J].Curr Opin Oneol, 2008, 20(3): 256-263.
  • 3吕汪霞,马胜林.西妥昔单抗的临床研究新进展[J].医学综述,2010,16(9):1345-1348. 被引量：8
  • 4Pryor D, Porceddu S, Burmeister B, et al. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer[J].Radiother Oncol, 90(2): 172- 176.
  • 5Baselga J. The EGFR as a targe for anti cancer therapy focus on cetuximab[J]. Eur J Cancer, 2001, 37(Suppl 4) : 16 22.
  • 6David E. Cetuximab in metastatic colorectal cancer[J]. London Cancer New Drugs Grorp-APC/DTC Briefing, 2005, 7(1) : 1-10.

二级参考文献24

  • 1Pirker R,Pereira JR,Szczesna A,et al.Cetuximah plus chemotherapy in patients with advanced non-small-cell lung cancer(FLEX):an open-label randomised phase Ⅲ trial[J].Lancet,2009,373 (9674):1525-1531.
  • 2O'Byrne KJ,Bondarenko I,Barrios C,et al.Molecular and clinical predictors of outcome for cetuximab in non-small cell lung cancer (NSCLC):Data from the FLEX study[J].J Clin Oncol,2009,27 (15S):8007.
  • 3Coate LE,Gately K,Barr MP,et al.Phase Ⅱ pilot study of neoadjuvant cetuximab in combination with cisplatin and gemcitabine in patients with resectable IB-ⅢA non small cell lung cancer[J].J Clin Oncol,2006,24(18S):17107.
  • 4Hanna N,Lilenbanm R,Ansari R,et al.Phase Ⅱ trial of cetuximab in patients with previously treated non-small-cell lung cancer[J].J Clin Oncol,2006,24 (33):5253-5258.
  • 5Herbst RS,Chansky K,Kelly K,et al.A phase Ⅱ randomized selectinn trial evaluating concurrent chemotherapy plus cetuximab or chemotherapy followed by cetuximab in patients with advanced non-small cell lung cancer(NSCLC):final report of SWOG 0342[J].J Clin Oncol,2007,25(18S):7545.
  • 6Vermorken JB,Mesia R,Rivera F,et al.Platinum-based chemotherapy plus cetuximab in head and neck cancer[J].New Engl J Med,2008,359:1116-1127.
  • 7Licitra L,Rolland F,Bokemeyer C,et al.Biomarker potential of EGFR gene copy number by FISH in the phase Ⅲ EXTREME study:Platinum-based CT plus cetuximab in first-line R/M SCCHN[J].J Clin Oncol,2009,27 (15S):6005.
  • 8Buentzel J,de Vries A,Micke O.Experience with cetuximab plus paclitaxel/carboplatinum in primary platinum-resistant recurrent head and neck cancer[J].J Clin Oncol,2007,25 (18S):6077.
  • 9Vermorken JB,Trigo J,Hitt R,et al.Open-label,uncontrolled,multicenter phase Ⅱ study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy[J].J Clin Oncol,2007,25 (16):2171-2177.
  • 10Van Cutsem E,Nowacki M,Lang I,et al.Randomized phase Ⅲ study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC):The CRYSTAL trial[J].J Clin Oncol,2007,25 (18S):4000.

共引文献7

华西医学
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部